Library / Laws / 114th Congress / House Bills / H.R. 1576

H.R. 1576

To require a study by the Government Accountability Office (GAO) to assess the Food and Drug Administration’s current regulatory pathway for reviewing generic versions of nonbiologic complex drug products, and for other purposes.

House · 1 version on the shelf